13F-HR filed by ACT CAPITAL MANAGEMENT, LLC
ACT CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 58 holding rows worth $123,670,400.
- Accession
- 0001636587-26-000006
- Filer
- CIK 1442273
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 59 entries on the cover page, a total value of $123,670,400 stated on the cover page (in dollars after the unit check, H1), rows summing to $123,670,400 with VALUE read as dollars as filed, 13F file number 028-21355. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 60,500 | $14,915,670 | dollars as filed | |
| Chevron Corporation | 166764100 | COM | 78,500 | $11,964,185 | dollars as filed | |
| EXXON MOBIL CORP | 30231G102 | COM | 82,500 | $9,928,050 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 63,900 | $8,617,235 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 268,875 | $8,015,164 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 206,100 | $7,250,598 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 63,415 | $6,325,012 | dollars as filed | |
| Amazon.com, Inc | 023135106 | COM | 24,600 | $5,678,172 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 610,500 | $5,470,080 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 75,000 | $4,979,250 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 64,500 | $4,098,330 | dollars as filed | |
| CELCUITY INC COM MAR 20 26 $50 CALL (CELC) | 8049179QM | OPTION | 30,500 | $3,042,070 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 38,500 | $2,677,675 | dollars as filed | |
| GRAYSCALE BITCOIN TRUST ETF | 389637109 | SHS REP COM UT | 34,400 | $2,351,584 | dollars as filed | |
| FIGURE TECHNOLOGY SOLUTIO | 349381103 | COM CL A | 57,500 | $2,348,300 | dollars as filed | |
| SPOTIFYTECHNOLOGYSAF | L8681T102 | STOK | 4,000 | $2,322,840 | dollars as filed | |
| ENERGY TRANSFER L P | 29273V100 | COM UT LTD PTN | 133,100 | $2,194,819 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 51,200 | $2,164,736 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 53,500 | $1,337,500 | dollars as filed | |
| International Business Machines Corporation | 459200101 | COM | 4,500 | $1,332,945 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 55,500 | $1,281,495 | dollars as filed | |
| CELCUITY INC COM MAR 20 26 $35 CALL (CELC) | 8049179KG | OPTION | 12,500 | $1,246,750 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 82,500 | $1,188,000 | dollars as filed | |
| BLOOM ENERGY CORP | 093712107 | COM | 13,000 | $1,129,570 | dollars as filed | |
| WARRIOR MET COAL INC | 93627C101 | COM | 12,000 | $1,058,040 | dollars as filed | |
| EOG RES INC COM | 26875P101 | Stock | 10,000 | $1,050,100 | dollars as filed | |
| SanDisk Corporation | 80004C200 | COM | 3,500 | $830,830 | dollars as filed | |
| DEVON ENERGY CORP NEW COM | 25179M103 | Stock | 22,000 | $805,860 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 47,000 | $770,330 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 73,900 | $767,821 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 23,000 | $717,830 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 61,500 | $597,780 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 12,000 | $528,600 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 7,000 | $528,360 | dollars as filed | |
| CRESCENT ENERGY COMPANY CL A COM | 44952J104 | Stock | 61,312 | $514,408 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 3,000 | $390,180 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 150,000 | $352,500 | dollars as filed | |
| ALPHA COGNITION INC | 02074J501 | COM NEW | 51,500 | $334,750 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 8,500 | $293,165 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 25,100 | $235,940 | dollars as filed | |
| BABCOCK & WILCOX ENTERPRISES | 05614L209 | COM | 36,500 | $231,410 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 41,000 | $212,380 | dollars as filed | |
| TERRA INNOVATUM GLOBAL NV | N85083108 | ORD SHS | 45,000 | $207,900 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 700 | $206,318 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 47,500 | $175,750 | dollars as filed | |
| LIGHTSPEED COMM INC NPV | 53229C107 | SUB VTG SHS | 12,500 | $151,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 12,900 | $120,228 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 3,000 | $114,630 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 9,000 | $108,720 | dollars as filed | |
| WEYERHAEUSER CO COM NEW | 962166104 | REIT | 4,500 | $106,605 | dollars as filed | |
| STRATASYS LTD | M85548101 | SHS | 10,000 | $86,800 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 7,500 | $84,675 | dollars as filed | |
| GRAYSCALE BITCOIN MINI TR ET | 389930207 | SHS NEW | 1,800 | $69,714 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 1,500 | $43,290 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 115,000 | $36,892 | dollars as filed | |
| Yalla Group Ltd | 98459U103 | COM | 5,000 | $34,700 | dollars as filed | |
| PDS BIOTECHNOLOGY CORP | 70465T107 | COM | 30,000 | $23,094 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,500 | $19,770 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001636587-26-000006 | this filing | 2026-02-17 | acceptance time not in the bulk data set |